Similar articles

• Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.

  Ziaei S, Moghasemi M, Faghihzadeh S. Ziaei S, et al. Climacteric. 2010 Apr;13(2):147-56. doi: 10.1080/13697130903009195. Climacteric. 2010. PMID: 19731119 Clinical Trial.
• Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.

  Wu MH, Pan HA, Wang ST, Hsu CC, Chang FM, Huang KE. Wu MH, et al. Climacteric. 2001 Dec;4(4):314-9. Climacteric. 2001. PMID: 11770188 Clinical Trial.
• Tibolone: the way to beat many a postmenopausal ailments.

  Lazovic G, Radivojevic U, Marinkovic J. Lazovic G, et al. Expert Opin Pharmacother. 2008 Apr;9(6):1039-47. doi: 10.1517/14656566.9.6.1039. Expert Opin Pharmacother. 2008. PMID: 18377345 Review.
• Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.

  Gregersen N, Jensen PT, Giraldi AE. Gregersen N, et al. Dan Med Bull. 2006 Aug;53(3):349-53. Dan Med Bull. 2006. PMID: 17092454 Review.
• Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women.

  Osmanağaoğlu MA, Atasaral T, Baltaci D, Bozkaya H. Osmanağaoğlu MA, et al. Climacteric. 2006 Dec;9(6):464-72. doi: 10.1080/13697130600997775. Climacteric. 2006. PMID: 17085380 Clinical Trial.